Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Metformin/sitagliptin extended release - GL PharmTech

Next Previous
Drug Profile

Metformin/sitagliptin extended release - GL PharmTech

Alternative Names: GLH-1SM; Sitagliptin HCl/metformin - GL PharmTech

Latest Information Update: 05 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GL PharmTech
  • Class Antihyperglycaemics; Biguanides; Fluorobenzenes; Insulin sensitisers; Ketones; Pyrazines; Small molecules; Triazoles
  • Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Diabetes mellitus

Most Recent Events

  • 05 Sep 2024 Preregistration for Diabetes mellitus (PO) (GL Pharmtech pipeline, September 2024)
  • 28 Feb 2022 No recent reports of development identified for phase-I development in Diabetes-mellitus(In volunteers) in South Korea (PO, Controlled release)
  • 11 Sep 2019 GL Pharm Tech completes a phase I trial in Healthy volunteers in South Korea (PO) (NCT03927170)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top